Min Hee Hong - Concepedia

Author

Min Hee Hong

Also Known As

Bok Jin Jung, Da-Yae Choi, Hong, M.H., Hong, Massimo, Hong, Min, Il-Soon Park, Kyung Hwan Kim, M H Hong, M Hong, M. H. Hong

653

Publications

6.4K

Citations

H-Index

145

Concepts

All Affiliations

Yonsei University Severance Hospital Jeuk (South Korea)Sungkyunkwan University Seoul National University

About

Min Hee Hong is an author at Yonsei University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	38	1.8K
2	Engineering	14	17	360
3	Health Sciences	7	7	213
4	Natural Sciences	3	3	107
5	Public Health	1	1	30

Min Hee Hong

126

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer Chun‐Gon Kim, Kyoung‐Ho Kim, Kyoung‐Ho Pyo, Annals of Oncology Pd-1/pd-l1 BlockadeNon-small-cell Lung CancerAdvanced Lung DiseaseMedicineImmunology	2019	296
Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer Jae-Won Cho, Min Hee Hong, Sang‐Jun Ha, Experimental & Molecular Medicine	2020	276
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion–Driven NSCLC Jiyeon Yun, Soo‐Hwan Lee, Seok‐Young Kim, Cancer Discovery	2020	272
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients Hye Ryun Kim, Sang‐Jun Ha, Min Hee Hong, Scientific Reports	2016	257
Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody James J. Harding, Víctor Moreno, Yung‐Jue Bang, Clinical Cancer Research	2021	155
Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer Yeona Cho, Sang Joon Park, Hwa Kyung Byun, International Journal of Radiation OncologyBiologyPhysics Cancer ImmunosurveillanceMedicineImmunologyBronchial NeoplasmImmune Checkpoint Inhibitor	2019	140
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study Myung‐Ju Ahn, Ji‐Youn Han, Ki Hyeong Lee, The Lancet Oncology Dose Expansion PartsDose EscalationMedicinePathologyCancer Treatment	2019	132
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares, Journal of Clinical Oncology	2024	130
Stimulation of asiaticoside accumulation in the whole plant cultures of Centella asiatica (L.) Urban by elicitors O. T. Kim, M. Y. Kim, Min Hee Hong, Plant Cell Reports PhytoalexinBotanyCentella AsiaticaPlant Cell CultureWhole Plant Cultures	2004	126
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer Jiyeon Yun, Min Hee Hong, Seok‐Young Kim, Clinical Cancer Research	2019	124

Page 1